<DOC>
	<DOCNO>NCT02899949</DOCNO>
	<brief_summary>Real-world data supplement knowledge gain traditional randomized control trial . To date , couple study ( Andrew et al . 2014 Wilding et al . 2015 ) conduct assess use dapagliflozin real-world clinical setting United Kingdom research do use dapagliflozin Canadian clinical practice setting . To investigator ' knowledge , real-world study exit assess impact use dapagliflozin conjunction insulin people type 2 diabetes mellitus dosage frequency insulin , oral antiglycemic agent hypertension drug . This study use electronic medical record-based data contains demographic , drug coverage , vitals , lab result , medical problem diabetes-related complication , medication prescription information patient diabetes receive care outpatient diabetes clinic London Ontario , Canada ass impact use dapagliflozin conjunction insulin patient type 2 diabetes mellitus health outcome , medication dose frequency .</brief_summary>
	<brief_title>Health Outcomes Patients With Type 2 Diabetes Treated With Dapagliflozin Conjunction With Insulin</brief_title>
	<detailed_description>Adult individual ( age≥18 ) type 2 diabetes mellitus receive care diabetes outpatient clinic St. Joseph 's Health Centre London ( Canada ) treat dapagliflozin conjunction insulin therapy select Web DR researchable database study . Web DR diabetes-specific , web-based , researchable , electronic medical record database . With exist electronic medical record tailor diabetes patient , system design implement Centre Diabetes , Endocrinology Metabolism St. Joseph 's Health Care London . The St. Joseph 's Centre Diabetes , Endocrinology Metabolism primary regional center diabetes endocrine disease management Southwestern Ontario . Web DR electronic medical record clinician-friendly pick-lists enable structured electronic medical record data collection point care , currently use 14 Endocrinologists three Family Physician Diabetologists outpatient diabetes clinic St. Joseph 's Health Care London , Canada . The baseline period 6 month allow complete observation comorbidities medication use pattern . HbA1c , lipid , blood pressure , weight clinical indicator measure baseline period ( close date dapagliflozin prescription ) follow-up period ( 3 6 month prescription dapagliflozin ) extract database . The last clinical value within follow-up period ≥30 day start medication data select follow-up information . The type insulin use dosage prescribe study follow-up period extract database examine insulin dosage prescription pattern understand use insulin dapagliflozin impact clinical outcome .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Type 2 diabetes mellitus &gt; 18 year age , diabetes patient insulin initiate dapagliflozin due need tight glycemic control glomerular filtration rate ( GFR ) &lt; 60 , pregnancy , type 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>dapagliflozin</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>real-world data</keyword>
</DOC>